000
| 01512cam 2200325za 4500 |
---|
001 | 9.858915 |
---|
003 | CaOODSP |
---|
005 | 20221107160124 |
---|
007 | cr ||||||||||| |
---|
008 | 180711s2018 onc o f000 0 eng d |
---|
020 | |a9780660271316 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH13-9/17-2018E-PDF |
---|
245 | 00|aGuidance document |h[electronic resource] : |buse of a foreign‐sourced reference product as a Canadian reference product. |
---|
246 | 30|aUse of a foreign‐sourced reference product as a Canadian reference product |
---|
246 | 17|aUse of a foreign‐sources reference product as a CRP |
---|
260 | |aOttawa : |bHealth Canada, |c2018. |
---|
300 | |a13 p. |
---|
500 | |aIssued also in French under title: Ligne directrice : utilisation d'un produit de référence étranger comme produit de référence canadien. |
---|
500 | |aCover title. |
---|
500 | |a"Date adopted: 2017/11/24. Effective date: 2017/11/24. Administrative changes date: 2018/07/12." |
---|
500 | |a"Publication date: July 2018." |
---|
500 | |aIssued also in HTML format. |
---|
693 | 4|aDrug approval |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tLigne directrice |w(CaOODSP)9.858918 |
---|
856 | 40|qPDF|s371 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-17-2018-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/canadian-reference-product-guidance.html |
---|